Pyxis Oncology PYXS
NASDAQ PYXS
$1.64 +0.01 (+0.61%)
At close: Nov 11, 2026 · 4:00 PM EST

Pyxis Oncology (PYXS) EBIT Margin (2024 - 2025)

Updated

Pyxis Oncology (PYXS) reported EBIT Margin of -165.75% for Q4 2025.

Analysis

Pyxis Oncology (PYXS) EBIT Margin (2024 - 2025) Analysis & Trends

For FY2025, Pyxis Oncology posted EBIT Margin of -609.18%, down 55.11 percentage points from FY2024.

  • By year, EBIT Margin came in at -554.07% in FY2024.
  • The Q4 2025 figure ranks as the highest quarterly EBIT Margin since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Pyxis Oncology 136.12 Mn -60.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -165.75%
Jun 30, 2025 -700.35%
Mar 31, 2024 -34.71%
API Access

Pyxis Oncology EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=PYXS&period=max&api_key=YOUR_API_KEY